Neurocrine Biosciences Inc Q2 adjusted earnings Beat Estimates

Neurocrine Biosciences Inc (NBIX) released a profit for second quarter that decreased from the same period last year.

The company's bottom line came in at $42.3 million, or $0.43 per share. This compares with $79.6 million, or $0.81 per share, in last year's second quarter.

Excluding items, Neurocrine Biosciences Inc reported adjusted earnings of $61.3 million or $0.63 per share for the period.

Analysts had expected the company to earn $0.49 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.

The company's revenue for the quarter fell 4.5% to $288.9 million from $302.4 million last year.

Neurocrine Biosciences Inc earnings at a glance:

-Earnings (Q2): $61.3 Mln. vs. $139.1 Mln. last year.
-EPS (Q2): $0.63 vs. $1.42 last year.
-Analysts Estimate: $0.49
-Revenue (Q2): $288.9 Mln vs. $302.4 Mln last year.

For comments and feedback contact: editorial@rttnews.com

Follow RTT